Adding a Reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenografts
- 31 October 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (11) , 1862-1868
- https://doi.org/10.1016/0959-8049(95)00386-w
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Response of Small-Cell Lung Cancer Xenografts to Chemotherapy: Multidrug Resistance and Direct Clinical CorrelatesJNCI Journal of the National Cancer Institute, 1993
- Response of a multidrug-resistant human small-cell lung cancer xenograft to chemotherapyZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Clinical Correlates of MDR1 (P-glycoprotein) Gene Expression in Ovarian and Small-Cell Lung CarcinomasJNCI Journal of the National Cancer Institute, 1992
- Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.Journal of Clinical Oncology, 1992
- Combined chemotherapy and radiotherapy in small-cell lung cancerPublished by Springer Nature ,1992
- Alternating radiotherapy and chemotherapy schedules in limited small cell lung cancer: analysis of local chest recurrencesRadiotherapy and Oncology, 1991
- Cell biology and molecular biology of small cell and non-small cell lung cancerCurrent Opinion in Oncology, 1990
- Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited diseaseInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell linesNature, 1985